Established in 2018 in Ljubljana, Slovenia, Bio-ReCell was founded to address the specific challenges faced by laboratories and clinics reliant on traditional magnetic-based cell separation and activation methods. Our founders recognized the industry's need for reliable alternatives that provide cleaner, residue-free results without proprietary restrictions. Driven by this vision, we developed our patented biocomposite materials with covalently bonded antibodies, allowing precise cell targeting without leaving contaminants or residues. Our mission is to free customers from restrictive and costly proprietary workflows, offering them open, adaptable technology platforms.

In 2023, we relocated to a new, modern facility officially inaugurated by Slovenian President Nataša Pirc Musar. This expansion has significantly enhanced our research and development capabilities, streamlined production processes, and enabled us to better support our growing customer base with advanced infrastructure and resources.

Our products leverage advanced, magnet-free cell processing methods:

Atract™ T-cell Activation Kit
Uses antibody-coated biocomposites to provide robust T-cell activation without residual contamination. Our method eliminates the cleanup steps required by traditional magnetic bead-based kits, speeding up the activation process and reducing potential cell damage.

Neptune™ T-cell Separation Kit
Offers gentle gravity-based separation of T-cells from mixed cell populations without magnets or centrifugation. Neptune™ consistently yields pure, viable T-cells, ideal for sensitive applications such as CAR-T therapy development.

Revive™ SVF Isolation System
Automates the isolation of Stromal Vascular Fraction (SVF) cells from adipose tissue. Revive™ delivers clinically relevant quantities of high-quality therapeutic cells quickly, efficiently, and without centrifugation, tailored specifically for regenerative therapies at point-of-care.

We operate a fully equipped 1,700 m² laboratory complex in Ljubljana, Slovenia. Our facility includes specialized chemistry and cell biology laboratories and a certified Biosafety Level 2 (BSL-2) microbiology lab, supporting rigorous product development, validation, and compliance with regulatory standards. The advanced infrastructure enables efficient translation of innovations from research to clinical-ready products.

We are dedicated to continuously advancing our product range and expanding applications in therapeutic areas such as cancer treatment, osteoarthritis management, and regenerative therapies. By offering versatile, cost-effective, and high-quality solutions, we aim to improve patient outcomes and empower researchers and clinicians worldwide.

For more information, visit our product pages or contact us at support@bio-recell.com.